CWGCX
Price
$68.12
Change
+$0.24 (+0.35%)
Updated
Jun 6 closing price
Net Assets
130.86B
MWECX
Price
$37.40
Change
+$0.25 (+0.67%)
Updated
Jun 6 closing price
Net Assets
2.19B
Interact to see
Advertisement

CWGCX vs MWECX

Header iconCWGCX vs MWECX Comparison
Open Charts CWGCX vs MWECXBanner chart's image
American Funds Capital World Gr&Inc C
Price$68.12
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets130.86B
MFS Global Equity C
Price$37.40
Change+$0.25 (+0.67%)
VolumeN/A
Net Assets2.19B
CWGCX vs MWECX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. MWECX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and MWECX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. MWECX (2.19B). CWGCX pays higher dividends than MWECX: CWGCX (0.87) vs MWECX (0.00). CWGCX was incepted earlier than MWECX: CWGCX (24 years) vs MWECX (31 years). MWECX (1.93) is less costly to investors than CWGCX (1.49). CWGCX is a more actively managed with annual turnover of: 27.00 vs. MWECX (8.00). CWGCX has a lower initial minimum investment than MWECX: CWGCX (250) vs MWECX (1000). CWGCX annual gain was more profitable for investors over the last year : 5.53 vs. MWECX (-8.34). CWGCX return over 5 years is better than : 42.30 vs. MWECX (-6.59).
CWGCXMWECXCWGCX / MWECX
Total Expense Ratio1.491.9078%
Annual Report Gross Expense Ratio1.491.9377%
Fund Existence24 years31 years-
Gain YTD8.7115.901148%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets131B2.19B5,982%
Annual Yield % from dividends0.870.00-
Returns for 1 year5.53-8.34-66%
Returns for 3 years26.86-14.30-188%
Returns for 5 years42.30-6.59-642%
Returns for 10 years49.3113.96353%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
PIII6.620.14
+2.24%
P3 Health Partners Inc
VSAT9.210.09
+0.99%
ViaSat
NLY19.060.18
+0.95%
Annaly Capital Management
RELI1.47-0.04
-2.65%
Reliance Global Group Inc.